Objective: The study aims to explore the association between lung function and the risk to develop PD.

Background: Some researchers have noted a faster decline in lung function among Parkinson’s disease (PD) patients compared to healthy individuals. However, the relationship between lung function and the risk of developing PD remains unknown.

Method: Based on the UK Biobank, Cox proportional hazards models were to investigate the relationship between lung function measurements, including forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and peak expiratory flow (PEF), and FEV1/FVC, and the risk of PD. Furthermore, the study constructed a lung function score and explore the relationship between the lung function score and PD risk. The study also conducted mediation analysis using blood inflammatory markers and metabolic indicators as mediators.

Results: The study included a total of 322,731 participants. We identified a correlation between lower lung function measures, particularly PEF, and an increased risk of PD. Our mediation analysis highlighted several inflammatory markers, such as eosinophil, lymphocyte, monocyte, neutrophil, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammatory index, reticulocyte, as mediators in the relationship between PEF and PD.

Conclusion: Declining lung function, especially PEF, could serve as a potential indicator for predicting the risk of PD. Inflammatory changes play a crucial role in the association, highlighting the significance of inflammatory alterations in the pathophysiology of PD.

figure1

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/lung-function-and-the-risk-of-parkinsons-disease-a-population-based-cohort-study/